array(3) { ["company_details"]=> array(13) { ["name"]=> string(28) "Bristol-Myers Squibb Company" ["slug"]=> string(37) "81631-us-bristol-myers-squibb-company" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13" ["description"]=> string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html" ["address_street"]=> string(19) "430 E 29TH St FL 14" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1887-02-28" ["website_domain"]=> string(7) "bms.com" ["website_url"]=> string(19) "https://www.bms.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(1200) ["article_count"]=> int(2495) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(104) "A123 Systems gets grant for battery management system with reverse bias protection for vehicle batteries" ["snippet_en"]=> string(183) "Discover the innovative patent by A123 Systems LLC for a cutting-edge battery management system with a protection circuit. Enhancing safety and efficiency for vehicle battery systems." ["url"]=> string(152) "https://www.power-technology.com/data-insights/a123-systems-gets-grant-for-battery-management-system-with-reverse-bias-protection-for-vehicle-batteries/" ["image_url"]=> NULL ["source"]=> string(20) "power-technology.com" ["publication_date"]=> string(10) "2024-03-28" ["categories"]=> array(1) { [0]=> string(21) "Competitive Behaviour" } } [1]=> array(7) { ["title_en"]=> string(76) "Cytokinetics with price explosion: Bristol-Myers Squibb again under pressure" ["snippet_en"]=> string(246) "With a price jump of around 75 percent, the share of the biotech company Cytokinetics is one of the absolute top performers on Wall Street on the Wednesday after Christmas and reached its highest level in around two decades (! December 27th, 2023" ["url"]=> string(138) "https://www.deraktionaer.de/artikel/pharma-biotech/cytokinetics-mit-kursexplosion-bristol-myers-squibb-erneut-unter-zugzwang-20346535.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/34d782bc-21df-4172-80de-efd1f30afb6b" ["source"]=> string(15) "deraktionaer.de" ["publication_date"]=> string(10) "2023-12-27" ["categories"]=> array(7) { [0]=> string(15) "Market Movement" [1]=> string(33) "Critical Incident Risk Management" [2]=> string(8) "Accident" [3]=> string(17) "Commodity Pricing" [4]=> string(21) "Competitive Behaviour" [5]=> string(24) "Employee Health & Safety" [6]=> string(12) "Stock Market" } } [2]=> array(7) { ["title_en"]=> string(38) "Bristol-Myers Squibb acquires RayzeBio" ["snippet_en"]=> string(127) "Bristol-Myers Squibb will acquire RayzeBio for $4.1 billion, or $62.50 per share, more than double the closing price on Friday." ["url"]=> string(81) "https://www.beursduivel.be/Nieuws/787575/Bristol-Myers-Squibb-koopt-RayzeBio.aspx" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b46885cc-7157-432d-a20e-0df20b5665c7" ["source"]=> string(14) "beursduivel.be" ["publication_date"]=> string(10) "2023-12-26" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(21) "Competitive Behaviour" [2]=> string(11) "Acquisition" } } [3]=> array(7) { ["title_en"]=> string(74) "Bristol-Myers plans billion-dollar acquisition | Stock exchanges newspaper" ["snippet_en"]=> string(105) "The pharmaceutical company Bristol-Myers Squibb plans to take over Karuna. The deal is worth $14 billion." ["url"]=> string(88) "https://www.boersen-zeitung.de/unternehmen-branchen/bristol-myers-plant-milliardenzukauf" ["image_url"]=> string(78) "https://images.businessradar.com/articles/63bf47c9-fc1c-4117-ac8e-9e357e28b031" ["source"]=> string(18) "boersen-zeitung.de" ["publication_date"]=> string(10) "2023-12-22" ["categories"]=> array(5) { [0]=> string(25) "Business Model Resilience" [1]=> string(11) "Acquisition" [2]=> string(15) "Deals & Tenders" [3]=> string(21) "Competitive Behaviour" [4]=> string(12) "Stock Market" } } [4]=> array(7) { ["title_en"]=> string(146) "In the wake of Bristol-Myers Squibb Company's (NYSE:BMY) latest US$4.1b market cap drop, institutional owners may be forced to take severe actions" ["snippet_en"]=> string(122) "Key Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price might be vulnerable..." ["url"]=> string(80) "https://au.lifestyle.yahoo.com/wake-bristol-myers-squibb-companys-130056610.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/5815bab6-60ef-4890-9e98-828b94157be1" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-09-07" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(21) "Competitive Behaviour" [2]=> string(11) "Acquisition" } } [5]=> array(7) { ["title_en"]=> string(73) "Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS" ["snippet_en"]=> string(121) "UBS believes there is little chance the lawsuits brought on by pharma companies will delay Medicare pricing negotiations." ["url"]=> string(118) "https://finance.yahoo.com/news/medicare-drug-price-negotiations-unlikely-to-be-derailed-by-lawsuits-ubs-165832314.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/d304c0c8-6c0b-422c-99c8-8a19d385cdea" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-08-21" ["categories"]=> array(2) { [0]=> string(5) "Legal" [1]=> string(21) "Competitive Behaviour" } } [6]=> array(7) { ["title_en"]=> string(79) "Bristol-Myers Squibb Company BDR Historical Price Data (BMYB34) - Investing.com" ["snippet_en"]=> string(191) "Get Bristol-Myers Squibb Company BDR historical price data for BMYB34 stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change." ["url"]=> string(83) "https://www.investing.com/equities/bristol-myers-squibb-company-bdr-historical-data" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> string(10) "2023-08-09" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(13) "Data Security" [2]=> string(21) "Competitive Behaviour" } } [7]=> array(7) { ["title_en"]=> string(62) "Will BMY Stock Price Continue Bullish Trend After Q2 Earnings?" ["snippet_en"]=> string(118) "1 BMY stock price showed a bullish trend last weekend. 2 On July 27, 2023, Thursday, Bristol-Myers Squibb Co. released" ["url"]=> string(105) "https://www.thecoinrepublic.com/2023/07/31/will-bmy-stock-price-continue-bullish-trend-after-q2-earnings/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4d623d9f-690d-4ad4-ae5f-f1d64387a985" ["source"]=> string(19) "thecoinrepublic.com" ["publication_date"]=> string(10) "2023-07-31" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(21) "Competitive Behaviour" } } [8]=> array(7) { ["title_en"]=> string(55) "Slight Gains in Bristol-Myers Squibb Stock (€55.8456)" ["snippet_en"]=> string(166) "Bristol-Myers Squibb stock is currently up on the US stock market. The most recent price was $62.68. An increase of 83 cents is currently pleasing the shareholders of" ["url"]=> string(135) "https://www.finanznachrichten.de/nachrichten-2023-07/59604030-leichte-zugewinne-bei-der-bristol-myers-squibb-aktie-55-8456-euro-013.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3ed7c9ad-0739-4687-be0f-d62f8179ba83" ["source"]=> string(20) "finanznachrichten.de" ["publication_date"]=> string(10) "2023-07-18" ["categories"]=> array(4) { [0]=> string(12) "Stock Market" [1]=> string(24) "Stock Research & Ratings" [2]=> string(21) "Shareholders Feedback" [3]=> string(21) "Competitive Behaviour" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(254) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(163) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(151) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(94) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(89) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(76) } [6]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(74) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(64) } [8]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(63) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(60) } [10]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(60) } [11]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(56) } [12]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(54) } [13]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(47) } [14]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(47) } [15]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(45) } [16]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(45) } [17]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(42) } [18]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(39) } [19]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(35) } [20]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(35) } [21]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(33) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(32) } [23]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(27) } [25]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(22) } [28]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(21) } } } 81631-us-bristol-myers-squibb-company